The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era

Bibliographic Details
Title: The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era
Authors: Parminder Singh, Sathvik Belagodu Sridhar, Javedh Shareef, Sirajunisa Talath, Priyanka Mohapatra, Mahalaqua Nazli Khatib, Suhas Ballal, Mandeep Kaur, Deepak Nathiya, Shilpa Sharma, G.V. Siva Prasad, Aashna Sinha, Amit Varma, Ganesh Bushi, Abhay M. Gaidhane, Prakasini Satapathy, Muhammed Shabil, Renu Sah, Jaffar A. Al-Tawfiq, Ranjit Sah, Alfonso J. Rodriguez-Morales
Source: New Microbes and New Infections, Vol 62, Iss , Pp 101487- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Mpox, Epidemiology, Transmission, Vaccination, Public health response, Antiviral treatment, Infectious and parasitic diseases, RC109-216
More Details: The recent global resurgence of Mpox (formerly monkeypox), primarily transmitted via close contact and respiratory droplets, highlights a significant shift in its epidemiology, particularly among men who have sex with men (MSM). This resurgence underscores the need for robust public health responses and improved surveillance. This comprehensive review of current literature focuses on recent outbreaks, virology, and available treatments. Epidemiological data were gathered from various international health reports and analysed to understand transmission dynamics and outbreak patterns. Mpox, characterised by symptoms like fever and rash, has shown variable clinical presentations, particularly among immunocompromised individuals. Recent outbreaks have prompted the development of new diagnostic methods and treatments, including antivirals like Tecovirimat and vaccines such as MVA-BN. Studies have demonstrated the effectiveness of these vaccines in preventing infection, which is crucial for outbreak containment. The global response to the Mpox resurgence requires integrated strategies combining vaccination, antiviral treatments, and public health policies tailored to high-risk populations. Future efforts should focus on vaccine distribution equity and enhancing diagnostic capabilities to effectively manage and mitigate the impact of Mpox.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2052-2975
Relation: http://www.sciencedirect.com/science/article/pii/S2052297524002713; https://doaj.org/toc/2052-2975
DOI: 10.1016/j.nmni.2024.101487
Access URL: https://doaj.org/article/645eb7bab7fd4ce7a51b9385bafdd1a2
Accession Number: edsdoj.645eb7bab7fd4ce7a51b9385bafdd1a2
Database: Directory of Open Access Journals
More Details
ISSN:20522975
DOI:10.1016/j.nmni.2024.101487
Published in:New Microbes and New Infections
Language:English